MiR-145 expression accelerates esophageal adenocarcinoma progression by enhancing cell invasion and anoikis resistance

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Derouet, Mathieu Francois ^a   Liu, Geoffrey ^b   Darling, Gail Elizabeth ^c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FIBRONECTIN; FLUOROURACIL; MICRORNA 145; VITRONECTIN; MICRORNA; MIRN145 MICRORNA, HUMAN;

ANOIKIS; ARTICLE; CANCER GROWTH; CELL ADHESION; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ESOPHAGEAL ADENOCARCINOMA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WOUND HEALING; ADENOCARCINOMA; DISEASE COURSE; DRUG EFFECTS; DRUG RESISTANCE; ESOPHAGUS TUMOR; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR INVASION;

ADENOCARCINOMA; ANOIKIS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; FIBRONECTINS; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS;

EID: 84920411025     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115589     Document Type: Article

References (32)

1. Blot WJ (1994) Esophageal cancer trends and risk factors. Seminars in oncology 21(4): 403-10.
2. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics 2002. CA Cancer J Clin 55: 74-108.
3. Hvid-Jensen F, Pedersen L, Drewes AM, Sorensen HT, Funch-Jensen P (2011) Incidence of adenocarcinoma among patients with Barrett's esophagus. NEJM 365(15): 1375-83.
4. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2): 281-97.
5. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2): 215-33.
6. Flynt AS, Lai EC (2008) Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nature Reviews Genetics 9(11): 831-42.
7. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nature Reviews Cancer 6(4): 259-69.
8. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers Nature Reviews Cancer 6(11): 857-66.
9. Ko MA, Zehong G, Virtanen C, Guindi M, Waddell TK, et al. (2012) MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy. Ann Thorac Surg 94(4): 1094-102.
10. Valeri N, Braconi C, Gasparini P, Murgia C, Lampis A, et al. (2014) MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer. Cancer Cell 25(4): 469-83.
11. Lin CW, Chang YL, Chang YC, Lin JC, Chen CC, et al. (2013) MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nat Commun 4:1877.
12. Chen Z, Zeng H, Guo Y, Liu P, Pan H, et al. (2010) miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc. J Exp Clin Cancer Res 29: 151.
13. Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, et al. (2010) MiR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 127(12): 2804-14.
14. Liu R, Liao J, Yang M, Sheng J, Yang H, et al. (2012) The cluster of miR-143 and miR-145 affects the risk for esophageal squamous cell carcinoma through co-regulating fascin homolog 1. PLoS One 7(3): e33987.
15. Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, et al. (2007) Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26(54): 7590-5.
16. Amir S, Ma AH, Shi XB, Xue L, Kung HJ, et al. (2014) Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer. PLoS One 8(4): e61064.
17. Tang F, Zhang R, He Y, Zou M, Guo L, et al. (2012) MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells. PLoS One 7(5): e35435.
18. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, et al. (2008) MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 14(9): 2690-5.
19. Le MT, Teh C, Shyh-Chang N, Xie H, Zhou B, et al. (2009) MicroRNA-125b is a novel negative regulator of p53. Genes Dev 23(7): 862-76.
20. Ozen M, Creighton CJ, Ozdemir M, Ittmann M (2008) Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27(12): 1788-93.
21. Fabbri M, Ivan M, Cimmino A, Negrini M, Calin GA (2007) Regulatory mechanisms of microRNAs involvement in cancer. Expert Opin Biol Ther 7(7): 1009-19.
22. Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, et al. (2009) Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 9: 374.
23. Yuan W, Sui C, Liu Q, Tang W, An H, et al. (2014) Up-Regulation of MicroRNA-145 Associates with Lymph Node Metastasis in Colorectal Cancer. PLoS One 9(7): e102017.
24. Pagliuca A, Valvo C, Fabrizi E, di Martino S, Biffoni M, et al. (2013) Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene 32(40): 4806-13.
25. Yin Y, Yan ZP, Lu NN, Xu Q, He J, et al. (2013) Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1. Biochimica et biophysica acta 1829(2): 239-47.
26. Peng X, GuoW, Liu T, Wang X, Tu X, et al. (2011) Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT. PLoS One 6(5): e20341.
27. Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110(6): 673-87
28. Roman J, Ritzenthaler JD, Roser-Page S, Sun X, Han S (2010) Alpha5beta1-integrin expression is essential for tumor progression in experimental lung cancer. Am J Respir Cell Mol Biol 43(6): 684-91.
29. Korah R, Boots M, Wieder R (2004) Integrin alpha5beta1 promotes survival of growth-arrested breast cancer cells: an in vitro paradigm for breast cancer dormancy in bone marrow. Cancer Res 64(13): 4514-22.
30. Mitra AK, Sawada K, Tiwari P, Mui K, Gwin K, et al. (2011) Ligand-independent activation of c-Met by fibronectin and alpha(5)beta(1)-integrin regulates ovarian cancer invasion and metastasis. Oncogene 30 (13): 1566-76.
31. Beausejour M, Thibodeau S, Demers MJ, Bouchard V, Gauthier R, et al. (2013) Suppression of anoikis in human intestinal epithelial cells: differentiation state-selective roles of alpha2beta1, alpha3beta1, alpha5beta1, and alpha6beta4 integrins. BMC Cell Biol 14: 53.
32. Liu D, Zhang XX, Wan DY, Xi BX, Ma D, et al. (2014) Sine oculis homeobox homolog 1 promotes alpha5beta1-mediated invasive migration and metastasis of cervical cancer cells. Biochem Biophys Res Commun 446: 549-554.